About the Journal
About the Journal
Artificial Intelligence and Digital Medical Humanities (AIDMH), founded in 2026, is an open-access, continuously published, and practice-oriented journal for the age of artificial intelligence. It explores the applications, implications, and critical examination of AI and digital technologies across medicine, health, and the humanities. The journal brings together healthcare practitioners, humanities scholars, technology developers, patients, and the public to promote responsible and creative collaboration among medicine, technology, and the humanities.
Focus and Scope
The journal welcomes work on topics including, but not limited to:
AI-assisted clinical communication, diagnosis, treatment, nursing, and health management;
digital medical humanities, narrative medicine, and patient experience;
applications of AI in medical education, research, and knowledge management;
digital transformation and human–AI collaboration in healthcare organizations;
algorithmic ethics, bias, fairness, privacy, accountability, and explainability;
health communication and digital literacy for patients and the public;
digital methods in medical history, philosophy, sociology, and cultural studies;
AI agents, automation tools, workflows, and their applications in medical humanities practice;
failures, negative results, risk incidents, and improvement retrospectives.
AIDMH publishes original research, reviews and perspectives, practice guides, workflows and standard operating procedures, Agent Skills and prompt protocols, cases and retrospectives, tools and data resources, commentaries, and responses.
Editorial Review and Publication
AIDMH follows a continuous publication model, under which accepted articles may be published online once the editorial and production processes have been completed. During its initial stage, the journal primarily uses a transparent editorial review process that evaluates authenticity, relevance, methodological transparency, actionability, reusability, ethical safety, and practical value. When specialist assessment is required, the journal may invite experts in the relevant field to provide reviews.
The journal does not misrepresent editorial review as conventional anonymous peer review. As the journal develops, it plans to establish a broader network of section editors, expert reviewers, and open-review mechanisms.
Open Access Policy
AIDMH is committed to open access. All formally published articles are freely available to read, download, and share without subscription fees.
Unless otherwise stated on the article page, published content is distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license permits copying, redistribution, adaptation, and reuse, provided that appropriate credit is given, the original source is identified, a link to the license is provided, and any changes are indicated.
Copyright Notice
Authors retain copyright in their work and grant the journal the right of first publication. Authors are responsible for ensuring that their submissions are original and lawful, and that permission has been obtained for any third-party text, images, data, audiovisual materials, code, or other content.
Submissions involving patients, research participants, or sensitive information must comply with applicable privacy, ethical, and informed-consent requirements. An open license does not remove the obligation to respect privacy, data-protection requirements, research ethics, or third-party rights.
Disclosure of AI Use
Authors must disclose the use of generative AI in topic development, information retrieval, analysis, writing, translation, image preparation, coding, or editorial revision, and must identify who verified the substantive content. AI tools cannot be listed as authors and cannot assume scholarly, legal, or ethical responsibility.
Sponsorship and Competing Interests
Authors, editors, and reviewers must disclose funding sources, commercial relationships, and other interests that could reasonably be perceived as influencing their judgment.
If the journal currently has no external sponsor, use this paragraph:
AIDMH is currently independently established and operated and does not receive commercial sponsorship that could compromise its editorial independence. Any future institutional, philanthropic, or commercial support will be publicly disclosed, together with the scope of the sponsor’s involvement. Sponsors will have no authority over decisions to review, accept, reject, correct, or retract submissions.
Privacy Statement
Names, email addresses, institutional affiliations, and other personal information submitted through this journal website will be used solely for editorial management, review, publication, notification, statistical analysis, and website administration. Such information will not be sold or used for unrelated commercial purposes.
Information may be processed or disclosed where required by law, necessary for an information-security investigation, or essential to maintaining publication integrity. Authors must appropriately anonymize personal information concerning patients, research participants, or other third parties and obtain any required ethical approval or informed consent before submission.
Digital Preservation
AIDMH is committed to the long-term preservation of its publications and supporting materials. The journal regularly backs up its database, submission files, published versions, and website configuration.
The journal is not currently enrolled in the LOCKSS or CLOCKSS preservation networks. Participation in LOCKSS, CLOCKSS, or another trusted digital preservation service will be considered as the journal develops. Until formal enrollment is completed, AIDMH will not claim that its content is preserved through either network.
Medical Disclaimer
Content published by AIDMH is intended for scholarly communication, education, and practical reference only. It does not constitute individualized medical advice and is not a substitute for professional diagnosis, treatment, or clinical decision-making. Articles involving clinical applications must clearly describe their intended users, conditions of use, risks, limitations, and requirements for human oversight.